Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200308547> ?p ?o ?g. }
- W4200308547 endingPage "e0259915" @default.
- W4200308547 startingPage "e0259915" @default.
- W4200308547 abstract "In the last years the rapid expansion of multidrug-resistant A. baumannii strains have become a major health problem. Efflux pumps are a group of transport proteins that contribute to the development of antibiotic resistance. The aim of this study was to evaluate the effect of the efflux pump inhibitor carbonyl cyanide 3-chlorophenylhydrazone (CCCP) on the antimicrobial action of imipenem and cefepime on clinical strains of A. baumannii.A total of 49 non-duplicate clinical samples were collected during January through December of 2018 from patients hospitalized in the Hospital Regional Docente de Cajamarca. Of the 49 samples obtained, the confirmatory identification of A. baumannii was performed on 47 samples by molecular methods. The amplification of the blaOXA-51-like gene was carried out by polymerase chain reaction (PCR). The determination of the minimum inhibitory concentration (MIC) was calculated using the microdilution method in culture broth. The susceptibility to both antibiotics (cefepime and imipenem) was evaluated in the presence and absence of the inhibitor carbonyl cyanide 3-chlorophenylhydrazone (CCCP).A total of 47 strains of A. baumannii were isolated: 97.87% (46/47) were resistant to Imipenem, 2.13% (1/47) of them were classified as intermediate and none of these strains were susceptible. On the other hand, 51.06% (24/47) of isolates were resistant to cefepime; 19.15% (9/47) intermediate and 29.79% (14/47) susceptible. We considered a significant difference in antibiotic susceptibility if the MIC changed at least 4 dilutions, after the addition of the inhibitor. In the case of CCCP in addition to imipenem, 2.1% (1/47) had a significant change of 4 or more reductions in MIC, 59.6% (28/47) achieved a change equal or less than 3 dilutions and 17.0% (8/47) did not have any change. In the case of CCCP with cefepime the percentage of strains with the significant change of MIC was 8.5% (4/47). On the other hand, 53.2% (24/47) presented a reduction equal or less than 3 dilutions and 12.8% (6/47) did not show changes.In conclusion, our results demonstrate that the use of CCCP may improve the antibiotic effect of imipenem and cefepime on clinical strains of A. baumannii. The relevance of this study is that it provides evidence that this efflux pump inhibitor may be an alternative treatment against multidrug-resistant A. baumannii." @default.
- W4200308547 created "2021-12-31" @default.
- W4200308547 creator A5036429475 @default.
- W4200308547 creator A5044155525 @default.
- W4200308547 creator A5055845749 @default.
- W4200308547 creator A5056685005 @default.
- W4200308547 creator A5060134864 @default.
- W4200308547 creator A5064639305 @default.
- W4200308547 creator A5084516698 @default.
- W4200308547 creator A5085600613 @default.
- W4200308547 creator A5090519528 @default.
- W4200308547 creator A5091888186 @default.
- W4200308547 date "2021-12-17" @default.
- W4200308547 modified "2023-10-18" @default.
- W4200308547 title "The effect of the efflux pump inhibitor Carbonyl Cyanide m-Chlorophenylhydrazone (CCCP) on the susceptibility to imipenem and cefepime in clinical strains of Acinetobacter baumannii" @default.
- W4200308547 cites W1995547459 @default.
- W4200308547 cites W2002150835 @default.
- W4200308547 cites W2023625688 @default.
- W4200308547 cites W2039125980 @default.
- W4200308547 cites W2052130550 @default.
- W4200308547 cites W2093616318 @default.
- W4200308547 cites W2101273146 @default.
- W4200308547 cites W2118637066 @default.
- W4200308547 cites W2121376278 @default.
- W4200308547 cites W2124712500 @default.
- W4200308547 cites W2133451445 @default.
- W4200308547 cites W2134442153 @default.
- W4200308547 cites W2135113667 @default.
- W4200308547 cites W2142663062 @default.
- W4200308547 cites W2152683133 @default.
- W4200308547 cites W2168891632 @default.
- W4200308547 cites W2323171068 @default.
- W4200308547 cites W2470515171 @default.
- W4200308547 cites W2589621467 @default.
- W4200308547 cites W2779019546 @default.
- W4200308547 cites W2809708644 @default.
- W4200308547 cites W2901881548 @default.
- W4200308547 cites W2919783273 @default.
- W4200308547 cites W2937960185 @default.
- W4200308547 cites W2948713507 @default.
- W4200308547 cites W2981337606 @default.
- W4200308547 cites W3011384320 @default.
- W4200308547 cites W3036500576 @default.
- W4200308547 cites W3087165857 @default.
- W4200308547 doi "https://doi.org/10.1371/journal.pone.0259915" @default.
- W4200308547 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34919563" @default.
- W4200308547 hasPublicationYear "2021" @default.
- W4200308547 type Work @default.
- W4200308547 citedByCount "14" @default.
- W4200308547 countsByYear W42003085472022 @default.
- W4200308547 countsByYear W42003085472023 @default.
- W4200308547 crossrefType "journal-article" @default.
- W4200308547 hasAuthorship W4200308547A5036429475 @default.
- W4200308547 hasAuthorship W4200308547A5044155525 @default.
- W4200308547 hasAuthorship W4200308547A5055845749 @default.
- W4200308547 hasAuthorship W4200308547A5056685005 @default.
- W4200308547 hasAuthorship W4200308547A5060134864 @default.
- W4200308547 hasAuthorship W4200308547A5064639305 @default.
- W4200308547 hasAuthorship W4200308547A5084516698 @default.
- W4200308547 hasAuthorship W4200308547A5085600613 @default.
- W4200308547 hasAuthorship W4200308547A5090519528 @default.
- W4200308547 hasAuthorship W4200308547A5091888186 @default.
- W4200308547 hasBestOaLocation W42003085471 @default.
- W4200308547 hasConcept C176947019 @default.
- W4200308547 hasConcept C185592680 @default.
- W4200308547 hasConcept C200082930 @default.
- W4200308547 hasConcept C2776315533 @default.
- W4200308547 hasConcept C2777050379 @default.
- W4200308547 hasConcept C2777637488 @default.
- W4200308547 hasConcept C2779631663 @default.
- W4200308547 hasConcept C2780950330 @default.
- W4200308547 hasConcept C501593827 @default.
- W4200308547 hasConcept C523546767 @default.
- W4200308547 hasConcept C54355233 @default.
- W4200308547 hasConcept C55493867 @default.
- W4200308547 hasConcept C86803240 @default.
- W4200308547 hasConcept C89423630 @default.
- W4200308547 hasConcept C94665300 @default.
- W4200308547 hasConceptScore W4200308547C176947019 @default.
- W4200308547 hasConceptScore W4200308547C185592680 @default.
- W4200308547 hasConceptScore W4200308547C200082930 @default.
- W4200308547 hasConceptScore W4200308547C2776315533 @default.
- W4200308547 hasConceptScore W4200308547C2777050379 @default.
- W4200308547 hasConceptScore W4200308547C2777637488 @default.
- W4200308547 hasConceptScore W4200308547C2779631663 @default.
- W4200308547 hasConceptScore W4200308547C2780950330 @default.
- W4200308547 hasConceptScore W4200308547C501593827 @default.
- W4200308547 hasConceptScore W4200308547C523546767 @default.
- W4200308547 hasConceptScore W4200308547C54355233 @default.
- W4200308547 hasConceptScore W4200308547C55493867 @default.
- W4200308547 hasConceptScore W4200308547C86803240 @default.
- W4200308547 hasConceptScore W4200308547C89423630 @default.
- W4200308547 hasConceptScore W4200308547C94665300 @default.
- W4200308547 hasIssue "12" @default.
- W4200308547 hasLocation W42003085471 @default.
- W4200308547 hasLocation W42003085472 @default.
- W4200308547 hasLocation W42003085473 @default.
- W4200308547 hasLocation W42003085474 @default.